Company Overview

Company name: Liberty Health Sciences (CNQ: LHS)
Description: Producer and distributor of pharmaceutical grade marijuana. The company engages in producing and distributing pharmaceutical grade marijuana using certified processing methods which lowers the cost of production, enabling customers to receive a clean and safe pharmaceutical-grade marijuana.
Year founded: 2017
Parent company:
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
Website: www.libertyhealthsciences.com
Employees: 75
City: Alachua
State: Florida
Country: United States
Region: Americas

Financial Highlights

Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Publicly Held
Exchange: CNQ
Ticker: LHS
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value: 279.39
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period: FY 2018
Financing Status: Aphria reached a definitive agreement to sell a 28.1% stake in the company for $59.1 million to undisclosed investors on September 6, 2018. Previously, Aphria sold its minority stake in the company (CSE: LHS) to Delavaco Group and Serruya Private Equity for CAD 33 million on February 5, 2018. The cost to Aphria of the divested shares was $0.234 per share, resulting in a gain to Aphria of approximately $27 million.
Number of active investors:
Profile last updated: 19-Sep-2018
Last known valuation: 210.32
Last known valuation date: 06-Sep-2018